Adaptive Biotechnologies Corporation

Seattle, WA Professional servicesNAICS 541700

Self-funded health planPlan year 2024Renews July
635ParticipantsFirst year on file
$1.5MEst. pharmacy spend / yrParticipants × national avg.
Jul 2027Next renewalPlan year begins July 1
#17 of 22Professional services in WABy participants

Overview

Adaptive Biotechnologies Corporation sponsors a self-funded health plan that covered 635 participants in plan year 2024. The plan year starts in July. Alongside medical, its benefits filing reports life insurance, dental, vision, short-term disability, and more.

Plan type
ERISA welfare benefit plan, self-funded (benefits paid from employer assets or a trust)
Participants
635
Plan year
Begins July 1 · next renewal July 2027
Health plans filed
Adaptive Biotechnologies Corporation Employee Benefit Plan, plan 501 (635 participants)
Broker compensation
$22K across insured contracts
MedicalLife insuranceDentalVisionShort-term disabilityLong-term disabilityDeath benefitsOther welfare benefits

Insurance carriers

Insured coverage reported on Schedule A. Self-funded medical claims aren't reported there.

CarrierCoverageCoveredPremiumBroker comp
Reliance Standard Life Insurance CompanyLife, Short-term disability, Long-term disability632$294K$22K
Vision Service PlanVision571$88K—
Curalinc LLCEmployee Assistance Program601$12K—
Wellspring Family Services EAPEmployee Assistance Program611$10K—

Pharmacy benefit estimate

StreamRX estimate for a plan this size. Not based on this plan's claims.

$1.5M/ year

Estimated prescription spend: 635 participants × $2,371 national average per member. Usually higher once dependents are counted.

$39K–$97K/ year

Typical savings opportunity found in independent reviews of plans this size.

Brands with a generic available$11K–$29K
Lower-cost therapeutic alternatives$17K–$35K
Generic pricing vs. actual cost$7K–$22K
PBM contract terms$4K–$11K
The DOL's PBM fee disclosure rule first applies to this plan for the plan year beginning July 2027: semiannual PBM compensation reports and an annual audit right.

Form 5500 filing details

Filing
Form 5500 with Schedule A, plan year 2024
Plan sponsor
Adaptive Biotechnologies Corporation
Sponsor EIN
27-0907024
Plan number
501
Filed with
U.S. Department of Labor (EBSA) via EFAST2

Verify this filing: search EIN 27-0907024 in the Department of Labor's EFAST2 Form 5500 search.

Retirement plan

Plan
Adaptive Biotechnologies Corporation 401(k) Plan
Type
401(k) plan
Participants
1,124

About this data

Source: Adaptive Biotechnologies Corporation's Form 5500 filing for plan year 2024 and its Schedule A insurance reports, published by the U.S. Department of Labor. "Self-funded" means the filing reports benefits paid from employer assets or a trust, with no medical insurance contract or with a stop-loss contract. Pharmacy figures are StreamRX estimates based on national averages. StreamRX is not affiliated with Adaptive Biotechnologies Corporation.

Request a correction · Methodology